Table 2.
Neurosteroid | ASD Males | TD Males | Levene’s Test | ||||
---|---|---|---|---|---|---|---|
N | Median (IQR) S-W Test W, P |
N | Median (IQR) S-W Test W, P |
F | P | ||
Allopregnanolone | Serum | 16 | 74.45 (26.0–91.1) W = 0.84, P = 0.01* |
17 | 99 (63.5–122.0) W = 0.97, P = 0.73 |
0.1773 | 0.6766 |
Saliva | 17 | 5 (5.0–52.0) W = 0.69, P < 0.001* |
18 | 5 (5.0–29.1) W = 0.68, P < 0.001* |
3.7547 | 0.06126 | |
Cortisol | Serum | 19 | 83900 (52300–92500) W = 0.77, P < 0.001* |
18 | 89950 (65450–102000) W = 0.79, P = 0.001* |
0.221 | 0.6412 |
Saliva | 20 | 2805 (1385.0–4705.0) W = 0.91, P = 0.05 |
19 | 1810 (1295.0–3200.0) W = 0.91, P = 0.08 |
2.9578 | 0.09382 | |
DHEA | Serum | 17 | 4030 (3230–5750) W = 0.83, P = 0.006* |
17 | 4340 (3570–6000) W = 0.93, P = 0.25 |
0.3241 | 0.5732 |
Saliva | 18 | 23.0 (10.0–91.7) W = 0.82, P = 0.003* |
18 | 94.10 (39.1–120.5) W = 0.91, P = 0.09 |
0.0964 | 0.7581 | |
Progesterone | Serum | 17 | 44.2 (22.9–62.1) W = 0.91, P = 0.12 |
16 | 58.3 (45.6–114.3) W = 0.84, P = 0.01* |
1.6549 | 0.2078 |
Saliva | 11 | 114.00 (73.4–192.0) W = 0.90, P = 0.20 |
10 | 5.0 (5.0–5.0) W = 0.47, P < 0.001* |
12.078 | 0.00253 | |
Testosterone | Serum | 17 | 3400 (1320.0–4640.0) W = 0.93, P = 0.22 |
17 | 3280 (1650.0–3790.0) W = 0.83, P = 0.005* |
0.0105 | 0.9191 |
Saliva | 18 | 45.45 (22.2–72.0) W = 0.88, P = 0.03* |
18 | 24.15 (16.1–36.7) W = 0.88, P = 0.02* |
2.9385 | 0.09559 |
Note: Units for all neurosteroids are pg/mL. IQR is Inter-Quartile Range, 25%–75%. S-W Test is Shapiro-Wilk test (* signifies non-normal distribution based on Shapiro-Wilk test P < 0.05). Bolded Levene’s test results are P < 0.05.